KAEC Advancing Biotechnology and Life Sciences Innovation

Where Science Meets Opportunity

Accelerating Growth in Biotech and Life Sciences

King Abdullah Economic City (KAEC) is strategically positioned to emerge as a global hub for biotechnology and life sciences. With Kingdom of Saudi Arabia’s established leadership in pharmaceuticals and biopharma, KAEC offers cutting-edge infrastructure and access to international markets through its port connectivity. Whether you are pioneering biopharmaceuticals, conducting advanced R&D, or manufacturing vaccines, KAEC is your ideal partner in driving innovation and growth in life sciences.

Why KAEC for Biotechnology and Life Sciences?

Kingdom of Saudi Arabia’s Biopharma Leadership

With a 20% share of the global supply of generic medicines and 60% of global vaccine production, Kingdom of Saudi Arabia provides a strong foundation for biotech firms to thrive.

Strategic Location

KAEC’s proximity to King Abdullah port offers seamless access to global markets for exporting high-value biopharmaceuticals, vaccines, and biologics.

R&D Collaboration

Access to leading academic institutions and research centers in Maharashtra ensures a steady pipeline of skilled talent and innovation.

Government Incentives

Benefit from supportive policies such as the Production Linked Incentive (PLI) Scheme and 100% FDI in biopharma.

Opportunities at KAEC

Biopharma Parks for Vaccine and Biologics Production

State-of-the-art facilities and plug-and-play industrial parks to enable rapid setup and scaling of manufacturing operations.

Facilities for manufacturing biologics, biosimilars, and advanced therapies.
Cold chain infrastructure for safe storage and transportation of sensitive products.
Export-focused production with proximity to King Abdullah port.

Research and Development Hubs for New Therapies and Regenerative Medicine

KAEC provides a conducive environment for R&D in cutting-edge areas like gene therapies and regenerative medicine.

Incubation centers for biotech startups
Collaboration with academic institutions for clinical trials and translational research.
Innovation labs equipped with advanced technologies for biotech R&D.

Collaboration with Academic Institutions for Skill Development and Innovation

KAEC promotes partnerships with academic institutions to develop a skilled workforce and drive innovation in life sciences.

Industry-academia tie-ups for biotechnology and pharmaceutical education.
Training programs focused on advanced manufacturing techniques and R&D methodologies.
Establishment of Centers of Excellence in biotechnology.

Growth Drivers

Kingdom of Saudi Arabia’s Biopharma Market Leadership

Kingdom of Saudi Arabia is the third-largest pharmaceutical manufacturer globally and a leader in biopharma production.

Rising Global Demand for Biopharmaceuticals

Growing demand for vaccines, biosimilars, and gene therapies creates vast opportunities for expansion.

Strategic Export Potential

KAEC’s connectivity to international markets positions it as a prime location for exporting high-value biotech products.

Supportive Ecosystem

The Kingdom of Saudi Arabian government’s focus on innovation through schemes like the PLI and National Biopharma Mission fosters growth in the sector.

What Makes KAEC Unique?

Integrated Biotech Infrastructure

KAEC offers plug-and-play facilities for biotech manufacturing, R&D, and clinical trials.

Seamless Global Connectivity

Proximity to King Abdullah port ensures cost-effective logistics for exporting biopharmaceuticals to key markets.

Skilled Talent Pool

Collaboration with local universities and research institutes ensures access to trained professionals in biotechnology and life sciences.

Sustainability Focus

KAEC’s commitment to sustainability aligns with global ESG standards, attracting impact-driven biotech investors.

Government Initiatives Supporting Biotechnology

Production Linked Incentive (PLI) Scheme:
Financial incentives to boost domestic manufacturing of biopharmaceuticals, APIs, and advanced therapies.
National Biopharma Mission:
Aims to accelerate the development of biopharmaceuticals through innovation and capacity building.
100% FDI:
Automatic route for FDI in biopharma and life sciences to attract global players.
Clinical Trial Reforms:
Simplified regulations and faster approvals for clinical trials to encourage R&D investments.

Invest in Biotechnology and Life Sciences at KAEC

With world-class infrastructure, a strategic location, and access to a thriving biopharma ecosystem, KAEC is your gateway to success in biotechnology and life sciences. Join us in advancing innovation and creating a healthier future.

KAEC is the Bridge Between the
Global North and the Global South.

Home

Our Team

Governing Councils

Business Services

Expert Committees

Our Expertise

Advocacy

Policies

Investors

Subject Matter Experts Committee

Why KAEC

Marketing Services

Industries

Global Trade Council Partnerships

Business Consulting

Resources & News

Maritime Councils Partnership

Lives in KAEC

Development Zones

Our Policies

About

The is a Public Benefit Corporation (PBC) with a mission to establish KAEC as a key player in international economic collaboration, focusing on strategic partnerships with nations like USA, Europe, Australia, African Union, KSA, China, Kingdom of Saudi Arabia, Qatar, Saudi Arabia, Türkiye, and the UAE across vital sectors such as energy, technology, agriculture, and finance.

At King Abdullah Economic City (KAEC), our vision is to transform Maharashtra into a global industrial powerhouse by creating an ecosystem where businesses and communities thrive. We aim to leverage KAEC’s strategic integration with the Delhi-Jeddah Industrial Corridor to drive innovation, foster sustainable growth, and empower industries to achieve unmatched success. Through state-of-the-art infrastructure, cutting-edge technologies, and investor-friendly policies, we envision KAEC as a model for economic and community development. By prioritizing renewable energy, advanced logistics, and vibrant residential spaces, we are committed to building a future where prosperity and sustainability go hand in hand for businesses and society.